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PCB-95Resveratrol (3,5,4′-trihydroxystilbene) (RSV), a polyphenol widely present in plants, exerts a neuroprotective
function in several neurological conditions; it is an activator of class III histone deacetylase sirtuin1 (SIRT1), a cru-
cial regulator in the pathophysiology of neurodegenerative diseases. By contrast, the RE1-silencing transcription
factor (REST) is involved in the neurotoxic effects following exposure to polychlorinated biphenyl (PCB)mixture
A1254. The present study investigated the effects of RSV-induced activation of SIRT1 on REST expression in SH-
SY5Y cells. Further, we investigated the possible relationship between the non-dioxin-like (NDL) PCB-95 and
REST through SIRT1 to regulate neuronal death in rat cortical neurons. Our results revealed that RSV signiﬁcantly
decreased REST gene and protein levels in a dose- and time-dependent manner. Interestingly, overexpression of
SIRT1 reduced REST expression, whereas EX-527, an inhibitor of SIRT1, increased REST expression and blocked
RSV-induced REST downregulation. These results suggest that RSV downregulates REST through SIRT1. In addi-
tion, RSV enhanced activator protein 1 (AP-1) transcription factor c-Jun expression and its binding to the REST
promoter gene. Indeed, c-Jun knockdown reverted RSV-induced REST downregulation. Intriguingly, in SH-
SY5Y cells and rat cortical neurons the NDL PCB-95 induced necrotic cell death in a concentration-dependent
manner by increasing REST mRNA and protein expression. In addition, SIRT1 knockdown blocked RSV-induced
neuroprotection in rat cortical neurons treated with PCB-95. Collectively, these results indicate that RSV via
SIRT1 activates c-Jun, thereby reducing REST expression in SH-SY5Y cells under physiological conditions and
blocks PCB-95-induced neuronal cell death by activating the same SIRT1/c-Jun/REST pathway.
© 2015 Elsevier Inc. All rights reserved.Introduction
Polychlorinated biphenyls (PCBs) are a large family of human
developmental neurotoxicants comprising 209 possible congeners
(McFarland and Clarke, 1989). They are generally divided into two
groups: PCB dioxin-like compounds and PCB non-dioxin-like com-
pounds (NDL). The former compounds bind to the aryl hydrocarbon
receptor (AhR), thereby exerting a marked toxicity similar to that of
polychlorinated dioxins and furans (Weintraub and Birnbaum, 2008).olychlorinated biphenyl non-
ene); EX-527, 6-chloro-2,3,4,9-
MS, oligodeoxynucleotide mis-
tin immunoprecipitation; LDH,
ing transcription factor; DCFH-
y, Department of Science and
Benevento, Italy.The latter compounds, instead, despite showing a very low afﬁnity for
AhR, also induce neurotoxic effects in vitro and in vivo (Giesy and
Kannan, 1998). We have previously shown that the PCB mixture
A1254 increases the repressor element 1 (RE1)-silencing transcription
factor (REST) mRNA and protein expression (Formisano et al., 2011)
through ERK2/Sp1/Sp3 pathway (Formisano et al., 2015a), which, in
turn, by recruiting HDAC3 on the Synapsin-1 promoter causes neuronal
death in cortical neurons (Formisano et al., 2015b). In mature neurons,
REST is quiescent, but it can be reactivated during normal postnatal de-
velopment, driving the switch from immature to mature NMDA recep-
tors (Rodenas-Ruano et al., 2012). Accordingly, REST has been closely
investigated in brain ischemia where it plays an important role in
determining neuronal death in hippocampal and cortical neurons
(Formisano et al., 2007, 2013, 2015c; Noh et al., 2012). One study, for in-
stance, reports that in insulted hippocampal neurons, casein kinase 1
suppresses activation of REST protein expression, thereby promoting
neuroprotection (Kaneko et al., 2014). Recently, there has been a grow-
ing interest in resveratrol (RSV) (3,5,4′-trihydroxystilbene), a polyphe-
nol contained in red wine and known to exhibit beneﬁcial effects in
388 N. Guida et al. / Toxicology and Applied Pharmacology 288 (2015) 387–398several neurological disorders such as Alzheimer Disease (Li et al.,
2012), Parkinson Disease (Wu et al., 2011), stroke (Morris et al., 2011)
and Amyotrophic Lateral Sclerosis (Mancuso et al., 2014). The most
commonly citedmechanism of action of RSV is the activation of the lon-
gevity factor silent mating type information regulation 2 homolog 1
(SIRT1) protein (Tang, 2010), a histone deacetylase (HDAC) that is
basally expressed in the adult mammalian brain, predominantly in neu-
rons (Donmez, 2012). SIRT1 utilizes nicotinamide (NAD+) (Donmez
and Outeiro, 2013) as a substrate to catalyze deacetylation of various
substrates involved in a broad range of physiological functions, includ-
ing control of gene expression, metabolism, and aging (Rahman and
Islam, 2011). Considering the role played by REST in PCB-induced neu-
rotoxicity, here we explored the mechanism by which resveratrol-
induced activation of SIRT1 blocks neurotoxicity after PCB exposure.
For this study, we evaluated how RSV via SIRT1 regulates REST mRNA
and protein expression in human neuroblastoma SH-SY5Y cells.
Furthermore, we studied the effect of NDL PCB-95 alone or in combina-
tionwith RSV on the survival of cortical neurons and its correlationwith
REST.
Material and methods
Drug and chemicals
The compound 2,3,6-2′,5′-pentachlorinated biphenyl (PCB-95)
(cod: RPC-130AS) (stock solution 305 μM) was purchased from Ultra
Scientiﬁc (North Kingstown, RI, USA). Culture media and sera were
obtained from Invitrogen (Milan, Italy). The SIRT1 activator 3,5,4′-
trihydroxy-trans-stilbene resveratrol (RSV) (cod. R5010; stock solu-
tion 10mM), H202 (cod. H1009; stock solution 10mM) and the 2′,7′-
dichloroﬂuorescin diacetate (DCFH-DA) (cod: D6883)were obtained
from Sigma-Aldrich (St. Louis, MO, USA). The SIRT1 inhibitor 6-
chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide EX-527 (cod.
sc-203044; stock solution 20 mM) was obtained from Santa Cruz Bio-
technology (Santa Cruz, CA, USA). For those requiring dilution in
DMSO, the ﬁnal DMSO concentration was 0.1% (vehicle). Under these
conditions, DMSO did not induce cellular toxicity.
Cell lines and culture conditions
Human neuroblastoma SH-SY5Y cells between the 10th and 30th
passage (IRCCS Azienda Ospedaliera Universitaria San Martino-IST-
Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy) were grown
as previously published (Cocco et al., 2015). Cells were incubated for
24 h with RSV and EX-527 at 1, 2, 5, and 10 μM and with PCB-95 at 1,
2, 4, 8 and 16 μM. For time-dependent experiments, cells were treated
with 8 μM RSV and 5 μM EX-527 for 6, 12, 24, and 36 h. Furthermore
RSV and EX-527 (both at 5 μM for 24 h) were simultaneously added
to themedium to study the effect on REST and c-Jun mRNA and protein
expression and the binding of c-Jun, RNA Pol II, and histone H4 acetyla-
tion on REST gene promoter. To evaluate the effects of PCB-95-induced
cell toxicity, SH-SY5Y cells were seeded and treated for 24 h with PCB-
95 at 1, 2, 4, 8, and 16 μM. Then, the effects of RSV on PCB-95-induced
neurotoxicity were explored by seeding and treating cells for 24 h
with RSV at 0.25, 0.5, 0.1, 1, 5 and 10 μM, alone or in combination
with 8 μM PCB-95. All the above mentioned experiments were per-
formed in DMEM medium containing 1% FBS to avoid loss of the PCB-
95 effect through binding to serum component. The experiments on
cortical neurons (DIV7) were approved by the Animal Care Committee
of “Federico II”, University of Naples, Italy and prepared as previously
described (Formisano et al., 2015b). In brief, cells were treated for
24 h with PCB-95 at 1,2,4, 8, and 16 μM, and with RSV at 6.25, 12.5,
and 25 μM.To study the effects of RSV on PCB-95-induced neurotoxicity,
neurons were seeded and treated for 24 h with vehicle, or with RSV
25 μMalone or in combinationwith 8 μMPCB-95. All these experiments
were performed in serum-free neurobasal medium. SH-SY5Y cells wereplated in 24-multiwell plates at a density of 2 × 104 for the LDH assay, in
6-multiwell plates at a density of 2.5 × 106 for the determination of free
radical production and in 100-mm well plates at a density of 10 × 106
for qRT-PCR, Western Blot, and ChIP analyses. Cortical neurons were
plated in 24-well plates at a density of 1 × 106 for LDH, and in 100-
mm well plates at a density of 15 × 105 for qRT-PCR and Western Blot
analyses.
Cell transfection
Anti-sense (AS) and missense (MS) phosphorothioate oligonucleo-
tides (ODNs) against human SIRT1, p65 (AS SIRT1, AS p65, MS SIRT1,
and MS p65), and human and rat c-Jun (AS c-Jun and MS c-Jun) were
transfected into SH-SY5Y cells and cortical neurons at a concentration
of 1 μM (Guida et al., 2014). Afterward, Opti-MEM was removed and
cells were incubated in freshmedium for 24 h.Western blot was subse-
quently carried out to test the knockdown efﬁciency. After ODN trans-
fection, experiments with PCB-95 alone or in combination with RSV
were carried out. In brief, cells were incubated for 24 h with 8 μM
PCB-95 alone or in combination with 5 μM RSV in SH-SY5Y cells or
with 25 μMRSV in cortical neurons. MS and AS oligonucleotides against
human SIRT1, c-Jun, p65 mRNA, and rat c-JunmRNA have already been
published (Ohkawa et al., 1999; Peterson et al., 2002; Hsieh et al., 2008;
Busch et al., 2012). SIRT1 silencing in cortical neurons by small interfer-
ing RNA (siRNA) was carried out as previously reported (Formisano
et al., 2015b). In brief, cells were transfected with scrambled control
(siCTL; sc-37007) and siRNAs against rat SIRT1 (siSIRT1; sc-108043) at
400 nM (Santa Cruz Biotechnology, Santa Cruz, CA).
After siRNA transfection, cells were incubated in a fresh medium for
24 h. Next, they were collected and subjected to western blotting to
assess knockdown efﬁciency. Alternatively, neurons were exposed to
PCB-95 (8 μM) alone or in combination with RSV (25 μM) for 24 h.
For SIRT1 overexpression experiments in SH-SY5Y cells, cells were
transfected with the empty vector pECE; the plasmid carrying SIRT1
cDNA was purchased from Addgene (cod: 1791) (Brunet et al., 2004).
For Western Blot and qRT-PCR analyses, cells were plated in 100-
mm dishes and transiently transfected for six hours with 15 μg of DNA
using Lipofectamine suspended in Opti-MEM. Next, Opti-MEM was re-
moved and replaced with fresh medium and cells were left to incubate
for 24 h. To evaluate cell transfection efﬁciency, siRNAs and ODNs were
mixedwith a plasmid encoding the enhanced green ﬂuorescent protein
marker; a ﬂorescence density of 50% for SH-SY5Y cells and 30%–50% for
cortical neurons, respectively, was detected (data not shown).
Lactate dehydrogenase (LDH) assay
LDH Cytotoxicity Kit (1000882) (Cayman, DBA, Milan, IT) was used
to assess cell death. LDH efﬂux into the medium was measured after
cortical neurons and SH-SY5Y cells were exposed to PCB-95 alone or
in combination with RSV for 24 h, respectively (Formisano et al.,
2015b). Triton X-100 Sigma-Aldrich (St. Louis, MO, USA) was used as
a positive control for cytotoxicity and its value was considered 100%.
Determination of reactive oxygen species (ROS) production
SH-SY5Y cells were treated with PCB 95 (8 μM) and RSV (5 μM),
alone or in combination, for 6 h and H2O2 (600 μM) for 30 min. After
that ROS production wasmeasured by 2′,7′-dichlorodihydroﬂuorescein
diacetate (DCF-DA) (Molecular Probes, Irvine, CA, USA) as previously
described (Amoroso et al., 1999; Pannaccione et al., 2005). Speciﬁcally,
cells were loaded with 10 μM DCF-DA for 30 min at 37 °C, in a medium
whose composition was in mM: NaCl 138, KCl 2.7, CaCl2 1.2, MgCl2 1.2,
PBS 10, glucose 10, pH 7.4 (standardmedium). After the loading period,
cells were washed thrice and the reaction was stopped by addition of
2,6-di-tert-butyl-4-methylphenol (0.2% in ethanol) and EDTA (2 mM).
Images were acquired by a ﬂuorescence microscope (Nikon Eclipse
389N. Guida et al. / Toxicology and Applied Pharmacology 288 (2015) 387–398E400) using an excitation wavelength of 488 nm. Then, images were
analyzed by ImageJ software.
Western blot analysis
Western blot analysis was performed as described elsewhere
(Formisano et al., 2011, 2015a; Sirabella et al., 2012; Guida et al.,
2014). Cells were lysed in lysis buffer containing 50 mM Tris–HCl,
pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, and protease and
phosphatase inhibitors. Samples (100 μg REST, SIRT1, Sp1, Sp3 and
70 μg c-Jun, phospho-c-Jun (p-c-Jun), p65, phospho-p65 (p-p65),
calpain, and pro- 3) were subjected to SDS-polyacrylamide gel electro-
phoresis (SDS-PAGE) and immunoblotted with speciﬁc antibodies.
Polyclonal antibodies were used against calpain (Formisano et al.,
2015b), p-c-Jun (Ser73) (cat: 9164 Cell-Signaling, EuroClone, Milan,
IT), c-Jun (cat: sc-1694), p65 (cat: sc-109), p-p65 Ser 536 (cat: sc-
33020), p65 (cat: sc-372), SIRT1 (cat: sc-15404), (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA), and REST (Iannotti et al., 2013;
Formisano et al., 2015b); β-Actin (Formisano et al., 2015b) was used
as loading control. All antibodies were used at a dilution of 1:1000 ex-
cept for p-p65 and p-c-Jun (1:250) and β-Actin (1:3000).
Chromatin immunoprecipitation (ChIP) assay
ChIP was performed as previously described (Formisano et al.,
2015b). In brief, after 24 h of seeding, cells were exposed to RSV
(5 μM) alone or in combinationwith EX-527 (5 μM) for 24 h. Afterward,
cells were cross-linked in 1% formaldehyde for 20 min at room temper-
ature. Cross-linking was stopped by adding glycine at 0.125M and cells
were washed twice in cold PBS containing proteinase inhibitors P-8340
(Sigma-Aldrich St. Louis, MO, USA). Next, they were lysed in 50 mm
Tris–HCl buffer (pH 8.1) containing 1% SDS, 10 mm EDTA, and protease
inhibitors prepared and sonicated to afford chromosomal DNA in the
range of 200–600 bp. At this point, samples were diluted with ChIP
dilution buffer (16.7 mm Tris–HCl, pH 8.1, 0.01% SDS, 1.1% Triton X-
100, 1.2 mm EDTA, 167 mm NaCl) to a ﬁnal volume of 1.0 ml. and
incubated with protease inhibitors. Twenty microliters of the pre-
immunoprecipitated lysatewas saved as “input” for later normalization.
DNA fragmentswere enriched by immunoprecipitationwith 3 μl anti-P-
c-Jun (Ser73) (cat: 9164 Cell-Signaling, EuroClone, Milan, IT), 5 μl anti-
H4 acetyl (06-866; polyclonal rabbit antibody; Millipore, Milan, Italy),
and 5 μl RNA POL II (R1530; Sigma-Aldrich St. Louis, MO, USA). IgG rab-
bit antibody was used as a negative control. After thermal cross-link re-
version and subsequent proteinase K digestion, DNA was puriﬁed by
phenol/chloroform extraction followed by ethanol precipitation. The ol-
igonucleotides used for the ampliﬁcation of the immunoprecipitated
DNA of human REST promoter were the following: Fw ChIP A1 5′-
CCTGCTACCTGCCACGTCTAGG-3′ Rv ChIP A1 5′-CCGCAGGCTTTGACGG
GTC-3, Fw ChIP A2 5′-GCATGCACGCCAGGGCTGGGGGG-3′ Rv ChIP A2
5′-GCCACCGCCCGCGGGACACGCC-3′, Fw ChIP B1 5′-GTGGGGCGCTGG
GCTGGGGGC-3′ Rv ChIP B1 5′-C CTCGGTGGAGCGTCCGGGCC-3′, Fw
ChIP B2 5′-CCAAGGAGCGGAGCTGCTCGGG-3′ Rv ChIP B2 5′-CACCCC
CGCGCCCCGGAAGTTTGCG-3′ Fw ChIP C 5′-GTAACTTTCCGTCCTCTCCC-
3′ Rv ChIP C 5′-GGCATTCGGCCATTTTCTC-3′ Fw AP-1 (a) site 5′-CCCG
GGCGGCGGCAGTGGC-3′ Rv AP-1 (b) site 5′-CGAGCAGCTCCGCTCCTT
GG-3′. The primers used for ChIP on human EPO promoter have already
been published (Dioum et al., 2009). The same set of primers used
for the B1 site was used for AP-1 (b). PCR was performed with the
SYBR Green detection and the results were visualized with ABI PRISM
7000 software (Applied Biosystems) The data were calculated with
the 2−ΔΔCt method (Formisano et al., 2015b).
Reverse transcription-real time PCR
Real-time RT-PCR was carried out with cDNAs reverse-transcribed
from total RNA by using Light Cycler-FastStart DNA Master SYBRGreen I (Roche; 03003230001 Foster City, CA) and ABI PRISM 7000 soft-
ware (Applied Biosystems) (Formisano et al., 2015b). The primer pairs
used for Synapsin-1, NCX1, and β-Actin were the same as those report-
ed elsewhere (Formisano et al., 2011; Vinciguerra et al., 2014). All reac-
tions were performed in triplicate in one assay with a non-template
blank for each primer pair as a control for contamination or primer–
dimer formation; the cycle threshold (CT) value for each experimental
group was determined. The results were normalized to the CT values
using the 2-ΔCt formula β-actin in the same sample. Differences in
mRNA content between groups were expressed as 2−ΔΔct (Formisano
et al., 2015b).
Statistical analysis
Data are expressed asmean±SEM. Statistical comparisons between
the experimental groups were performed using one way ANOVA
followed by Newman Keuls test. P value b0.05 was considered statisti-
cally signiﬁcant.
Results
RSV reduces REST mRNA and protein expression in a time- and
dose-dependent way in SH-SY5Y cells
SH-SY5Y cells were incubated with a non toxic concentration of RSV
(5 μM) (Lee et al., 2007) at different time points (6 to 36 h), and expres-
sion levels of REST mRNA were determined by q-RT-PCR. REST mRNA
expression was signiﬁcantly reduced by RSV at 6 h as compared to
vehicle, reaching a maximum reduction at 24 h of incubation (Fig. 1a).
At 24 h, different concentrations of RSV reduced REST mRNA in a
dose-dependent manner (Fig. 1b). Western blot analysis showed that
after 12 h of RSV incubation, REST protein expression was signiﬁcantly
reduced, reaching a maximum reduction at 24 h as compared to vehicle
(Fig. 1c) in SH-SY5Y cells. In addition, RSV-induced-REST reduction was
dose dependent (Fig. 1d). These experiments identiﬁed 5 μM of RSV as
the concentration that produced an intermediate degree of reduction
of REST gene and gene product.
SIRT1 reduces REST mRNA and protein expression in SH-SY5Y cells
It is known that RSV regulates SIRT1 protein expression and
deacetylase activity (Seo et al., 2012). q-RT-PCR andWestern Blot anal-
ysis showed that RSV (5 μM/24 h) did notmodify SIRT 1mRNA and pro-
tein expression (Suppl. Fig. 1a and b). Interestingly, when SH-SY5Y cells
were treated with the SIRT1 inhibitor EX-527 (1 to 10 μM), REST gene
expression and protein levels signiﬁcantly increased in a dose and
time-dependent manner compared with vehicle (Fig. 2a–d). These re-
sults suggest that RSV modulates SIRT1 activity, but it has any effects
on SIRT1mRNAand protein. Likewise,when SH-SY5Y cells were treated
with RSV in the presence of EX-527, RSV-induced reduction of REST
mRNA and protein expression was completely blocked (Fig. 2e,f). To
further conﬁrm that RSV through SIRT1 decreases REST protein expres-
sion, RSV-treated cells were transfectedwith speciﬁc antisense andmis-
sense oligonucleotides for SIRT1 (AS SIRT1 andMS SIRT1, respectively).
Notably, AS SIRT1 transfection was able to decrease SIRT1 protein by al-
most 75% (Suppl. Fig. 2a). As well, AS SIRT1 signiﬁcantly blocked REST
mRNA and protein reduction as compared to cells transfected with MS
SIRT1. Interestingly, when cells were transfected with AS SIRT1, REST
mRNA and protein expression levels increased (Fig. 2I, m), whereas
when they were treated with a construct overexpressing SIRT1
(Brunet et al., 2004) by almost 60% (Suppl Fig. 2b), REST mRNA and
protein levels decreased (Fig. 2l, n). We then asked whether REST re-
duction is functional. To answer this question, we performed q-RT-
PCR to examine the gene expression of two REST target genes, viz, the
sodium\calcium exchanger 1 (NCX1) (Formisano et al., 2013) and
Synapsin-1 (Formisano et al., 2011) in SIRT1 silenced or overexpressing
Fig. 1.RSV reduced RESTmRNA andprotein expression indose and timedependentmanner in SH-SY5Y cells. a,b) q RT-PCRand representativeWestern blot of RESTprotein at 6, 12, 24 and
36 h of RSV (5 μM) exposure. Bars represent mean ± S.E.M. obtained in three independent experiments. Graphs show quantiﬁcation of the ratio of REST to β-Actin. *P b 0.05 vs vehicle;
**P b 0.05 vs RSV at 12 h. c,d) q RT-PCR and representative Western blot of REST protein incubated for 24 h at 1, 2, 5 and 10 μM of RSV. Bars represent mean ± S.E.M. obtained in four
independent experiments. Graphs show quantiﬁcation of the ratio of REST to β-actin.*P b 0.05 vs vehicle or RSV 1 μM; **P b 0.05 vs all.
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mRNA expression as compared to MS SIRT1 (Suppl. Fig. 2c,e), whereas
SIRT1 overexpression signiﬁcantly increased NCX1 and Synapsin-1
mRNA as compared to the empty vector (Suppl. Fig. 2d,f).
SIRT1 does not bind to human REST promoter sequence in vivo
Since RSV regulates gene expression by increasing SIRT1 binding to
the promoter sequence (Pezzolla et al., 2015), we investigated whether
SIRT1 binds to the REST human promoter (GenBank accession no.
AB024498). The rationale for this experiment was that the REST
promoter sequence comprises three alternative promoters A, B, and C
that regulate the exons a, b and c (Fig. 2o). Interestingly, each exon
can splice directly into exon d, which contains the ATG translation initi-
ation site of REST sequence (Koenigsberger et al., 2000; Ravache et al.,
2010). Accordingly, we divided the two alternative REST promotersequences A and B into two different fragments A1, A2 and B1, B2, re-
spectively, whereas the C promoter sequence, termed C1,was left intact
(Fig. 2o). ChIP experiments with SIRT1 antibody were performed using
speciﬁc primers for these ﬁve fragments of the REST promoter. In RSV-
treated cells, when chromatin was precipitated with SIRT1 antibody,
no signal was detected in all REST promoter fragments. However, in
SH-SY5Y cells, SIRT1 was able to bind only to the promoter sequence
of its known target gene, erythropoietin (EPO) (Dioum et al., 2009), as
compared to control IgG (Fig. 2q). This result suggests that SIRT1 does
not bind to the REST human promoter sequence in SH-SY5Y cells.
RSV through c-Jun reduces REST mRNA and protein expression
REST human gene promoters have multiple binding sites for the
following transcription factors: activator protein-1 (AP-1), nuclear
factor-kappa B (NF-kB), and speciﬁcity protein 1 (Sp1) (Ravache et al.,
Fig. 2. RSV, via SIRT1, decreases REST mRNA and protein without binding to its promoter sequence in SH-SY5Y cells. a–d) q RT-PCR and representative Western blot of REST protein in-
cubated for 24 h at 1, 2, 5 and 10 μMEX-527 (a,b) and for 6, 12, 24 and 36 h at 5 μMEX-527 (c,d). Bars representmean± S.E.M. obtained in three independent experiments. Graphs show
quantiﬁcation of the ratio of REST to β-actin. *P b 0.05 vs vehicle**P b 0.05 vs all. e,f) q RT-PCR and representative Western blot of REST mRNA and protein incubated for 24 h with RSV
(5 μM) alone or in combination with EX-527 (5 μM). Bars represent mean ± S.E.M. obtained in four independent experiments. *P b 0.05 vs vehicle **P b 0.05 vs RSV alone. g,h) q RT-
PCR and representative Western blot of REST mRNA and protein incubated for 24 h with RSV (5 μM) alone or after transfection with AS SIRT1. Bars represent mean ± S.E.M. obtained
in three independent experiments. *P b 0.05 vs vehicle **P b 0.05 vs RSV + MS SIRT1. i–n) qRT-PCR (i,l) and representative WB and quantiﬁcation of REST (m,n) protein expression in
SH-SY5Y cells after transfection with MS SIRT1 and AS SIRT1 or pECE (empty vector), and a construct overexpressing SIRT1 (SIRT1). Each column represents the mean ± S.E.M. obtained
in four independent experiments (*P b 0.05 vs MS SIRT1 or empty vector). o) Map of the human REST gene indicating the exons a, b, and c downstream of the alternative promoters A, B,
and C, respectively, and exon Dwhich contains the translation initiation site, situated as+1, and the PCR primers used to detect the presence of speciﬁc DNA sequences in ChIP complexes
in A1, A2, B1, B2 and C1 regions of REST promoters. p) ChIP analysis of the A1, A2, B1, B2 and C1 regions of REST promoters performed with anti-SIRT1 and anti-IgG (used as negative
control). The binding activity of SIRT1 is graphically represented as the percentage of total input of chromatin DNA. q) ChIP analysis of the EPO promoter region performed with anti-
SIRT1 and anti-IgG. The binding activity of SIRT1 is graphically represented as the percentage of total input of chromatin DNA. Bars representmean± S.E.M. obtained in three independent
experiments. *P b 0.05 versus Ab-IgG.
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REST reduction, we treated cells with RSV for 6, 12, and 24 h. Western
Blot analysis showed that phospho p65 (p-p65) and p-c-Jun subunits
of the NF-kB and AP-1 complexes were increased time dependently at
6, 12 and 24 h (Fig. 3a,b). Interestingly, RSV did not modify Sp1 and
Sp3 protein expression (Fig. 3c,d).
Then, to evaluate the role of p65 and c-Jun in RSV-induced REST
mRNA and protein reduction, p65 and c-Jun were knocked down in
SH-SY5Y cells with antisense oligonucleotides (AS ODNs) (Fig. 3e,f).
Notably, AS ODNs for c-Jun (AS c-Jun) and p65 (AS p65) signiﬁcantly
reduced c-Jun and p65 expression by 60% and 70%, respectively, as
compared to MS c-Jun and MS p65 (Fig. 3e,f). Interestingly, only AS
ODN against c-Jun, but not against p65, reverted the reduction of RSV-
induced REST gene and protein expression as compared to vehicle
(Fig. 3g,h). Notably, AS c-Jun did not modify REST protein expression
in non RSV-treated cells (Suppl. Fig. 3c).RSV increases c-Jun expression and binding to the AP-1 (b) binding site of
REST promoter sequence
qRT-PCR revealed that c-Jun mRNAwas signiﬁcantly increased after
6, 12, and 24 h of RSV (5 μM) treatment, as compared to vehicle
(Fig. 4a). Importantly, qRT-PCR and Western blotting at 12 h showed
that EX-527 reduced RSV-induced mRNA and protein expression
(Fig. 4b,c). Notably, EX-527 did not modify P-c-Jun protein expression
in non RSV-treated cells (Suppl. Fig. 3a). Two putative AP-1 binding
sites have previously been identiﬁed on the REST gene human promoter
sequence at−2168/−2162 and−1990/−1984 from the transcription
start site (TSS) (+1) (GenBank accession no. AB024498) (Ravache
et al., 2010) (Fig. 4d). Thus, to test whether c-Jun could bind directly
to these sites, which we named AP-1 (a) (−2168/−2162) and AP-1
(b) (−1990/−1984) (Fig. 4d), after RSV treatment, we performed
ChIP. Interestingly, when chromatin from cells treated with vehicle
Fig. 3. Effect of RSV on Sp1, Sp3, p65, and c-Jun protein expression and of ODNs against c-Jun and p-65 on RSV-reduced REST mRNA and protein expression in SH-SY5Y cells. a–d) Rep-
resentativeWestern blot of P-p65, P-c-Jun, Sp1, and Sp3 proteins at 6, 12, 24 h of RSV (5 μM) exposure. Bars represent mean± S.E.M. obtained in three independent experiments. Graphs
showquantiﬁcation of the ratio of p65, c-Jun, Sp1, and Sp3 toβ-actin. Bars representmean±S.E.M. obtained from three independent experiments. P*b 0.05 vs vehicle; **P b 0.05 vs all. e,f)
RepresentativeWestern blot and quantiﬁcation of p65 and c-Jun protein expression in SH-SY5Y cells after transfectionwithmissense (MS) p65 and antisense (AS) p65, orMS c-Jun andAS
c-Jun. Graphs show quantiﬁcation of the ratio of p65 or c-Jun to β-actin. Bars representmean± S.E.M. obtained from three independent experiments. *P b 0.05 vsMS c-Jun. g,h) qRT-PCR
and representativeWestern blot of the effect of MS and AS for p65 and c-Jun, respectively, on RSV-reduced RESTmRNA and protein expression. Bars represent mean± S.E.M. obtained in
four experiments for qRT-PCR and three experiments for Western blot. Graphs show quantiﬁcation of the ratio of REST to β-actin. Bars represent mean ± S.E.M. obtained from three
independent experiments. *P b 0.05 vs vehicle; **P b 0.05 vs MS c-Jun.
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the AP 1 (b) site, but not that including the AP-1 (a) site, was ampli-
ﬁed as compared with control IgG. Moreover, the binding activity of
c-Jun to AP-1 site (b), but not to AP-1 site (a), was markedly in-
creased after RSV treatment (Fig. 4d,e), in parallel with a decrease
in RNA Pol II binding and histone H4 acetylation, as compared to
vehicle (Fig. 4f–g). Interestingly, RSV-increased binding activity of
c-Jun or the decreased binding of RNA Pol II and histone H4 acetyla-
tion to AP-1 (b) site was reverted by co-application of EX-527
(Fig. 4d–g). These data suggest that SIRT1 increases c-Jun binding
to the REST gene promoter at the AP 1 (b) site, thereby reducing
REST gene transcription.Resveratrol reduced PCB-95-induced cell death by blocking the increase in
REST mRNA and protein levels in SH-SY5Y cells
Exposure of PCBmixture A-1254 for 24 h at 30.6 μMreduces SH-SY5Y
cell survival by about 50% through an increase in RESTmRNAandprotein
expression (Formisano et al., 2015a, 2015b). Since the A1254 mixture
consists primarily of NDL PCBs (N99%) (Ingleﬁeld et al., 2001), we tested
the effect of NDL congener PCB-95 on neuronal death. Interestingly, we
found that 24 h exposure to PCB-95 (1–16 μM) induced neuronal cell
death in a concentration-dependent manner, as evaluated by LDH
assay (Fig. 5a). Since 8 μMPCB-95 induced a 50% reduction in cell surviv-
al, this concentration was used for further experiments. To investigate
Fig. 4. Effect of EX-527 on RSV-induced c-Jun mRNA and protein expression and on RSV-induced binding to AP-1 (b) site of REST promoter sequence in SH-SY5Y cells. a) qRT-PCR of the
effect of RSV on c-Jun mRNA at 6, 12 and 24 h. Bars represent mean ± S.E.M. obtained from four independent experiments. *P b 0.05 vs vehicle **P b 0.05 vs all. b,c) qRT-PCR and repre-
sentativeWesternblot of c-JunmRNA and protein co-incubated for 12 hwith RSV (5 μM)alone or in combinationwith EX-527 (5 μM). Graphs showquantiﬁcation of the ratio of REST toβ-
actin. Bars representmean ± S.E.M. obtained in three independent experiments. *P b 0.05 vs vehicle **P b 0.05 vs RSV alone. d) Schematic representation of human REST gene indicating
the exons a, b, and c and the alternative promoters A, B and C; PCR primers used to detect the presence of speciﬁc DNA sequences in ChIP complexes in AP-1 (a) and (b) regions of REST
promoter. e–h) ChIP of the regions containing the AP-1 (a) and AP-1 (b) sites on the REST gene promoter carried out with anti-c-Jun (e,f) and ChIP of the regions containing the AP-1
(b) site carried out with anti-RNA-POL II and histone H4 acetylation (g,h) in SH-SY5Y cells incubated for 12 h with RSV (5 μM) alone or in combination with EX-527 (5 μM). The binding
activity of c-Jun, RNA-POL II, and histone H4 acetylation is graphically represented as the percentage of total input of chromatin DNA. Bars represent mean ± S.E.M. obtained from three
independent experiments. *P b 0.05 vs IgG, **P b 0.05 vs vehicle and ***P b 0.05 vs RSV alone.
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RSV at concentrations of 0.25, 0.5, 1, 5 and 10 μM. LDH assays showed
that cell survival signiﬁcantly improved in a dose dependent manner
when cells were co-treated with RSV, as compared to cells exposed
to PCB-95 alone (Fig. 5b) and that RSV affordedmaximum protection
at 5 μM. In addition, at 24 h, PCB-95-induced increase in REST mRNA
and protein expression was reverted after RSV (5 μM) treatment
(Fig. 5c,d).
Importantly, since REST overexpression diminished H2O2-induced
cell death reducing production of reactive oxygen species (ROS)
and consequent apoptosis activation (Lu et al., 2014) we performed
experiments to evaluate whether PCB-95-induced neurotoxicity wasassociated to oxidative stress and inﬂammation. In particular, free radi-
cal production was monitored by DCF-DA in neuroblastoma cells
exposed to PCB 95 (8 μM), RSV (5 μM) alone or in combination. As
shown in Supplemental Fig. 4a, after 6 h PCB 95 (8 μM) alone or in
combination with RSV (5 μM) failed to modify intracellular ROS levels.
On the other hand, ROS levels signiﬁcantly increased when cells were
exposed to H2O2, that is a known oxidative stress stimulus (Lu et al.,
2014). Furthermore PCB 95 exposure did not cause any change of
P-p65 expression (Suppl. Fig. 4b), suggesting a lack of involvement
of the inﬂammation marker in the neurotoxic effect of the pollutant.
Collectively these results indicate that oxidative stress and inﬂamma-
tion are not associated to PCB-95-induced neurotoxicity.
Fig. 5. Effect of PCB-95 alone or in combinationwith RSV on cell survival and on REST expression in SH-SY5Y cells. a) Effects of 24 h exposure to PCB-95 at 1, 2, 4, 8, and 16 μMon SH-SY5Y
cell death, as evaluated by LDH assay. For LDH experiments, 1% Triton X-100was used as positive control and its valuewas considered as 100%. Each bar represents mean± SEM obtained
from 5 independent experimental sessions.*P b 0.05 vs vehicle and PCB-95 at 1 and 2 μM, **P b 0.05 vs PCB-95 at 4 μM, ***P b 0.05 vs all. b) Effect of 8 μMPCB-95 at 24 h, alone orwith 0.25,
0.5, 1, 5 and 10 μMRSV on LDH release. Bars representmean± S.E.M. obtained in four independent experiments. *P b 0.05 vs vehicle; **P b 0.05 vs PCB-95 alone and PCB-95+RSV at 0.25
and 0.5 μM; ***P b 0.05 vs all. c,d) q RT-PCR and representativeWestern blot of REST in SH-SY5Y cells treated for 24 hwith PCB-95 (8 μM)alone or in combinationwith RSV (5 μM). Graphs
show quantiﬁcation of the ratio of REST to β-actin. Bars represent mean ± S.E.M. obtained in three independent experiments. *P b 0.05 vs vehicle; **P b 0.05 vs PCB-95 alone.
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REST pathway in cortical neurons
When cortical neurons were exposed to different concentrations of
PCB-95 (1–16 μM; Fig. 6a) for 24 h, a dose-related increase in cell
death was observed, as evidenced by LDH assay. As in SH-SY5Y cells,
PCB-95 at 8 μM was able to reduce cell viability by about 50% and was
therefore chosen for our experiments in cortical neurons. It is notewor-
thy that cell death induced by PCB-95 (8 μM) at 24 h was inhibited in a
concentration-related manner when RSV was added to the culture
medium at different concentrations (6.25–50 μM) (Fig. 6b); notably,
maximum neuroprotection was obtained with 25 μM RSV. Similarly,
the increase in REST mRNA and protein expression induced by PCB-95at 24 h was blocked upon addition of RSV (25 μM) (Fig. 6c,d). Notably,
PCB-95-induced increase in calpain expression was blocked by RSV
co-application; in contrast, the apoptotic marker procaspase-3 was
unmodiﬁed (Fig. 6e,f). Moreover, PCB-95-induced decrease in P-c-Jun
was reverted by RSV, as compared to the vehicle (Fig. 6g).
We next investigated the function of c-Jun and SIRT1 in RSV-blocked
PCB-95-induced REST gene and gene product increase. To this aim, we
knocked down c-Jun and SIRT1 with ODN for c-Jun (AS c-Jun) and
with siRNA for SIRT1 (siSIRT1). Notably, siSIRT1 and AS ODNs for c-Jun
signiﬁcantly reduced SIRT1 and c-Jun expression by 55% and 65%,
respectively (Suppl. Fig. 3b,d).
Intriguingly, transfection of AS c-Jun and siSIRT1 blocked RSV capa-
bility to reduce PCB-95-induced REST mRNA and protein expression as
Fig. 6. Effect of PCB-95 alone or in combination with RSV on neuronal survival and on P-c-Jun, SIRT1, and REST expression. a) Effects of 24 h exposure to PCB-95 at 1, 2, 4, 8, and 16 μM
on cortical neurons death, measured by LDH. Each bar represents mean ± SEM obtained from four independent experimental sessions.*P b 0.05 vs vehicle, PCB-95 at 1 and
2 μM;**P b 0.05 vs PCB-95 at 4 μM and ***P b 0.05 vs all. b) Effect of 8 μM PCB-95 at 24 h, alone or with 6.25, 12.5, 25, and 50 μM RSV on LDH release. Bars represent mean ± S.E.M.
obtained in ﬁve independent experiments. *P b 0.05 vs vehicle; **P b 0.05 vs vehicle, PCB-95 alone and PCB-95 + RSV 6.25 μM; ***P b 0.05 vs all. c) qRT-PCR of REST mRNA in neurons
treated for 24 h with PCB-95 (8 μM) alone or in combination with RSV (25 μM). Bars represent mean ± S.E.M. obtained in three independent experiments. *P b 0.05 vs vehicle and
**P b 0.05 vs PCB-95 alone. d–g) Western blots of REST, pro-caspase 3, calpain, and P-c-Jun protein levels in vehicle after 24 h of PCB-95 (8 μM), alone or in combination with RSV
(25 μM). Graphs show quantiﬁcation of the ratio of REST, pro-caspase 3, calpain and c-Jun to β-actin. Bars represent mean ± S.E.M. obtained from three independent experiments.
*P b 0.05 vs vehicle; **P b 0.05 vs PCB-95 alone. h,i) qRT-PCR and Western blot analysis of REST in neurons transfected with MS and AS ODNs for c-Jun or of siRNAs, siCTL, and siSIRT1
for SIRT1 to block the reducing effect of RSV on PCB-95-induced REST gene and gene product expression. Bars representmean± S.E.M. obtained in four independent experiments. Graphs
showquantiﬁcation of the ratio of REST toβ-actin. *Pb 0.05 vs PCB-95 alone; **P b 0.05 vs PCB-95+RSV. l) Effects of 24h exposure to PCB-95 8 μMoncortical neuronal death, asmeasured
by LDH in vehicle, siCTL and when PCB-95 was administered alone or after siREST transfection and when PCB-95 was administered in combination with RSV alone or after siSIRT1 trans-
fection. For LDH experiments, 1% Triton X-100 was used as positive control and its value was considered as 100%. Each bar represents the mean± S.E.M. obtained from ﬁve independent
experiments. *P b 0.05 versus vehicle or siCTL, ** P b 0.05 versus PCB-95 alone.
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respectively (Fig. 6h,i). Then, to evaluate the role of REST in PCB-95-
induced toxicity, we knocked down its expression. Particularly, siRNA
for RESTwas recently published (Formisano et al., 2013, 2015b). Unsur-
prisingly, siREST transfection reduced PCB-95-induced neurotoxicity
(Fig. 6l). Interestingly, co-incubation with RSV signiﬁcantly reduced
the detrimental effect of PCB-95, as compared to vehicle (Fig. 6l).Notably, siRNA transfection against SIRT1 completely abolished RSV-
induced neuroprotection in cortical neurons exposed to PCB-95 (Fig. 6l).
Discussion
In the present study,we showed that resveratrol (RSV) reduces REST
expression at the transcriptional level via activation of SIRT1. As a result,
396 N. Guida et al. / Toxicology and Applied Pharmacology 288 (2015) 387–398SIRT1 increases c-Jun mRNA and protein expression, thus causing an
increase in its binding activity to the REST human gene promoter
sequence in SH-SY5Y cells. In particular, overexpression of SIRT1
suppressed REST expression, whereas the speciﬁc SIRT1 inhibitor EX-
527 (Yan et al., 2013) increased it. In addition, we showed that in corti-
cal neurons RSV, through SIRT1 and c-Jun, suppressed PCB-95-induced
neurotoxicity caused by REST mRNA and protein upregulation. To our
knowledge, this is the ﬁrst report showing that RSV downregulates
REST in neuronal cells. Furthermore, RSV-induced suppression of REST
was reversed by EX-527, a well known inhibitor of SIRT1, thereby sug-
gesting that RSV suppressed REST expression through SIRT1 activation
at the transcriptional level. Indeed, we identiﬁed c-Jun, a subunit of
the AP-1 complex, as the transcriptional factor that down-regulates
REST after RSV treatment. More speciﬁcally, we evidenced that of
the four identiﬁed putative transcription factors regulating REST
(Ravache et al., 2010), RSV was able to increase the phosphorylation
of only c-Jun and p65 proteins, whereas Sp1, Sp3, which are known to
regulate REST mRNA expression (Ravache et al., 2010; Formisano
et al., 2015a), were unmodiﬁed. Most important, c-Jun, but not p65,
knockdown was able to block RSV-induced REST mRNA and protein
expression in SH-SY5Y neuroblastoma cells.
Such evidence led us to a secondmajor ﬁnding. Indeed, to the best
of our knowledge, this is the ﬁrst report showing that c-Jun is a REST
transcriptional repressor. This result expands ﬁndings from previous
reports showing that Jun homodimers may be activators or repres-
sors depending on the context of the promoter, the sequence of the
cognate DNA-binding site, the cell phenotype, and the environmen-
tal milieu of the cell, i.e., conditions that favor quiescence or prolifer-
ation (Ubeda et al., 1999). Moreover, within the human REST gene
promoter, we identiﬁed two AP-1motifs (AP-1 a and AP-1 b), located
at −2168/−2162 and −1990/−1984 from the transcription start
site (TSS), as possible molecular determinants involved in c-Jun-
induced REST regulation (Ravache et al., 2010). Notably, ChIP re-
vealed that RSV induced c-Jun binding exclusively to the AP-1
(b) site, which was completely abolished when cells were treated
with the SIRT 1 inhibitor EX-527 a result suggesting the involvement
of SIRT 1 in c-Jun-induced REST regulation. On the other hand, we
found that in RSV-treated cells, SIRT1 did not bind to any of the
REST promoter fragments. Given these results, we speculate that
REST downregulation induced by RSV and mediated by SIRT1 is not
due to the direct binding of SIRT1 to the REST gene promoter but,
rather, to the participation of c-Jun. Moreover, evidence for the inter-
play between c-Jun and SIRT1 is that the increase in RSV-induced c-
Jun mRNA and protein expression was reverted by EX-527 treat-
ment. Our results also characterized the binding site of c-Jun on
REST human promoter; in fact, only the AP-1 (b) site of the two pu-
tative AP-1 elements present on the REST promoter sequence was
important for c-Jun binding after RSV treatment. Interestingly, c-
Jun binding to the AP-1 (b) site was reverted by EX-527, thus
conﬁrming even further the key role played by SIRT1 in this
interaction.
Our results are in accordance with previous reports demonstrating
that RSV causes an increase in c-JunmRNA (Shih et al., 2002). Consider-
ing the key role played by SIRT1 in this process, we could hypothesize
that RSV was able to increase SIRT1 binding to c-Jun gene promoter se-
quence. Such increased SIRT1 binding then determined an increase in its
mRNA and protein expression that, in turn, by interacting with REST
promoter sequence, downregulated its expression.
Evidence for RSV neuroprotective effect also emerged when cells
were treated with non-dioxin like (NDL) polychlorinated biphenyl
95 (PCB-95). We found that NDL-PCB-95 induced neuronal cell
death in a concentration dependent manner and that RSV reverted
this effect. Interestingly, exposure to NDL-PCB-95 at 8 μM damaged
approximately 50% of SH-SY5Y cells and cortical neurons. However,
RSV counteracted PCB-induced cell death at 5 μM in SH-SY5Y and
at 25 μM in cortical neurons. These results conﬁrm earlier ﬁndingsdemonstrating that RSV induces neuroprotection at 25 μM in neuro-
nal primary cultures (Sakata et al., 2010) and at 5 μM in SH-SY5Y
cells (Lee et al., 2007), and that primary neurons are more resistant
to RSV neuroprotection.
Intriguingly, we found that SIRT1 knockdown blocked RSV- in-
duced neuroprotection in neurons, thereby corroborating the hy-
pothesis that RSV via SIRT1 activation determines neuronal
survival. In fact, speciﬁc siRNAs against SIRT1 are known to abolish
RSV-induced neuroprotection in in vitro models of brain ischemia
(Wang et al., 2013) and in retinal ganglion cells after H2O2 treatment
(Khan et al., 2012).
Moreover our results are also in line with the neuroprotective role
played by c-Jun. In fact, c-Jun over-expressing cells are more resistant
to okadaic acid-induced apoptosis (Dragunow et al., 2000) and its in-
duction in ischemic conditioning is able to rescue CA1 hippocampal
from neuronal death (Sommer et al., 1995).
It has been shown that REST protects against oxidative stress down-
regulating apoptotic gene expression whereas in this paper we found
that REST up-regulation induced by PCB-95 determines cell-death.
However, the toxic pathways triggered by oxidative stress and PCB-95
seem to be different. In fact oxidative stress, inﬂammation and apopto-
sis do not occur in our experimental conditions. Indeed PCB-95 expo-
sure failed to increase ROS production and the expression of P-p65
protein, a marker of inﬂammation. Furthermore in PCB-95 treated
cells a necrotic and not an apoptotic cell death occur. Our ﬁndings sug-
gest that oxidative stress, apoptosis and inﬂammation are not associat-
ed to PCB-95 induced neurotoxicity in our experimentalmodel, and that
RSV-induced neuroprotection is mediated by SIRT1/c-Jun pathway, that
counteracts REST increase. Consistently, we have previously shown that
PCBmixture A1254 through REST induces necrotic cell death in neurons
(Formisano et al., 2011, 2015a, 2015b). Regarding the PCB concentra-
tions tested in the present study, they have already been used in previ-
ous reports and arewithin the range of PCBs detected inwildlife animals
(Mariussen et al., 2002). Speciﬁcally, PCB-95, but not other PCBs or
polybrominated diphenyl ethers (PBDEs), is signiﬁcantly higher in post-
mortem brains of children with a syndromic form of autism, compared
with neurotypical controls (Mitchell et al., 2012). Furthermore, PCB-95
crosses the blood–brain barrier and can interact with targets (Kania-
Korwel et al., 2012).
Collectively, these results indicate that resveratrol through SIRT1/c-
Jun pathway regulates REST expression at the basal level in SH-SY5Y
neuronal cells and is involved in the neurotoxic effect of NDL PCB-95.
Furthermore, these results indicate that resveratrol exerts a neuropro-
tective effect against the toxic effect of PCBs by increasing SIRT1 activity
that in turn causes a reduction in c-Jun binding to the REST promoter
sequence.
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